Results
21,591 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Nagendran SukumarDirector, President and Head of R&D |  TSHATaysha Gene Therapies, Inc.Open-market sale | SELL | $423K 89.1K sh | Jan 27, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Nagendran SukumarDirector, President and Head of R&D | TSHATaysha Gene Therapies, Inc. Open-market sale | SELL | $423K 89.1K sh | Jan 27, 2026 |
| 30 | Kuffner JamesCHIEF TECHNOLOGY OFFICER |  SYMSymbotic Inc.Open-market sale | SELL | $63K 1,048 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 30 | Walsh John FCEO-The Americas |  ACNAccenture plcOpen-market sale · 10b5-1 plan | SELL | $718K 2,600 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 25 | Alam KamranCHIEF FINANCIAL OFFICER | TSHATaysha Gene Therapies, Inc. Open-market sale | SELL | $110K 23.8K sh | Jan 27, 2026 traded Jan 26, 2026 |
| 25 | Nagendran SukumarDirector, President and Head of R&D | TSHATaysha Gene Therapies, Inc. Open-market sale | SELL | $124K 26.9K sh | Jan 27, 2026 traded Jan 26, 2026 |
| 24 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $1.56M 51.9K sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $119K 429 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $117K 421 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $74K 263 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 23 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $64K 227 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $144K 524 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 20 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $3,360 12 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $17K 62 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $283 1 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $145K 514 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $30K 107 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 18 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $244K 8,135 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 15 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER |  LTHLife Time Group Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $360K 12.1K sh | Jan 27, 2026 traded Jan 23, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $20K 71 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $567 2 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $47K 168 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $8,904 32 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner |  TEAMAtlassian CorpOpen-market sale · 10b5-1 plan | SELL | $265K 1,913 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 |  Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $364K 2,664 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $270K 1,988 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $364K 2,663 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $270K 1,987 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $265K 1,914 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 6 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $131K 951 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $131K 950 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $6,652 50 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $13K 100 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $6,652 50 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector |  SCHWSCHWAB CHARLES CORPOpen-market sale | SELL | $1.00M 9,525 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations |  MUMICRON TECHNOLOGY INCOpen-market sale | SELL | $3.32M 8,500 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $2.81M 7,200 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector | SCHWSCHWAB CHARLES CORP Open-market sale | SELL | $2.00M 19.1K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Schwab-Pomerantz CarolynDirector | SCHWSCHWAB CHARLES CORP Open-market sale | SELL | $1.00M 9,525 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 35 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $1.99M 5,128 sh | Jan 26, 2026 traded Jan 22, 2026 |